A venture capital headquartered in Europe was built on foundation of an incubator which has been operating since 2017. The firm invests in early-stage companies in the pre-seed and seed rounds, offering up to €250K tickets, with the possibility of follow-on investments. The firm invests globally, with a focus on European businesses. The firm offers convertibles and priced rounds, where the firm typically follows (or co-leads), and can assign a technical and business mentor to each team, tailoring the cooperation to the needs of each startup.
The firm is sector-agnostic but exclusively focused on disruptive AI-driven solutions. The firm requires a testable prototype or proof-of-concept (POC) and initial business traction and is happy to look into B2B or B2C.
The firm requires companies to have an established team of founders.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment